Investing.com - Aphria announced second quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The company reported earnings per share of C$0.01 on revenue of C$160.5M. Analysts polled by Investing.com EPS of C$-0.0305 on revenue of C$153.15M. .
Aphria 's are up 44.32% , still down 2.61% from its 52 week high of C$13.04 set on Wednesday, January 13, 2021.
Aphria follows other major Healthcare sector earnings this month
On Tuesday, OrganiGram Holdings Inc first quarter EPS of C$-0.17 on revenue of C$19.33M, a forecasts for EPS of C$-0.036 on revenue of C$21.64M.
Immunoprecise Antibodies earnings matched analysts' expectations on Wednesday, December 30, 2020, with second quarter EPS of C$0.00 on revenue of C$4.75M. Investing.com analysts EPS of C$0.00 on revenue of C$4.75M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar